MENU
+Compare
LLY
Stock ticker: NYSE
AS OF
May 30 closing price
Price
$737.67
Change
+$15.10 (+2.09%)
Capitalization
739.66B

LLY Eli Lilly & Co Forecast, Technical & Fundamental Analysis

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology... Show more

LLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for LLY with price predictions
May 30, 2025

LLY in +2.54% Uptrend, rising for three consecutive days on May 30, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where LLY advanced for three days, in of 357 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 52 cases where LLY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on May 29, 2025. You may want to consider a long position or call options on LLY as a result. In of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for LLY turned negative on May 06, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

LLY moved below its 50-day moving average on May 01, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for LLY crossed bearishly below the 50-day moving average on May 09, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LLY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for LLY entered a downward trend on May 30, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. LLY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: LLY's P/B Ratio (67.114) is very high in comparison to the industry average of (5.632). P/E Ratio (131.129) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (1.440) is also within normal values, averaging (3.004). Dividend Yield (0.006) settles around the average of (0.161) among similar stocks. LLY's P/S Ratio (20.121) is very high in comparison to the industry average of (3.643).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

View a ticker or compare two or three
LLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

LLY is expected to report earnings to rise 65.87% to $5.54 per share on August 07

Eli Lilly & Co LLY Stock Earnings Reports
Q2'25
Est.
$5.54
Q1'25
Missed
by $0.12
Q4'24
Beat
by $0.02
Q3'24
Missed
by $0.27
Q2'24
Beat
by $1.18
The last earnings report on May 01 showed earnings per share of $3.34, missing the estimate of $3.46. With 6.11M shares outstanding, the current market capitalization sits at 739.66B.
A.I.Advisor
published Dividends

LLY is expected to pay dividends on June 10, 2025

Eli Lilly & Co LLY Stock Dividends
A dividend of $1.50 per share will be paid with a record date of June 10, 2025, and an ex-dividend date of May 16, 2025. The last dividend of $1.50 was paid on March 10. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Lilly Corporate Center
Phone
+1 317 276-2000
Employees
43000
Web
https://www.lilly.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MNKD4.140.02
+0.61%
MannKind Corp
GGAL58.05-0.12
-0.21%
Grupo Financiero Galicia SA
CMPX2.11-0.01
-0.47%
Compass Therapeutics
TGT94.01-0.86
-0.91%
Target Corp
ACRV1.07-0.04
-3.18%
Acrivon Therapeutics

LLY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, LLY has been loosely correlated with AZN. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if LLY jumps, then AZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LLY
1D Price
Change %
LLY100%
+2.09%
AZN - LLY
45%
Loosely correlated
+2.72%
NVS - LLY
42%
Loosely correlated
+2.82%
OGN - LLY
39%
Loosely correlated
-3.35%
MRK - LLY
32%
Poorly correlated
+0.58%
PFE - LLY
30%
Poorly correlated
+0.17%
More